ANDA 83923, held by Chartwell Rx. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 83923 (Phentermine Hydrochloride), held by Chartwell Rx, was first approved by FDA on Jul 1, 1976, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 1, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride8MG · tablet;oral | Phentermine Hydrochloride | Discontinued |
| Jul 24, 2025 | Supplement 48Labeling · Standard review | Approved | None posted |
| Oct 6, 2000 | Supplement 47Manufacturing | Approved | None posted |
| Jun 1, 1999 | Supplement 45Labeling | Approved | None posted |
| Apr 8, 1998 | Supplement 44Labeling | Approved | None posted |
| Dec 19, 1997 | Supplement 43Labeling | Approved | None posted |
| Oct 16, 1992 | Supplement 41Manufacturing | Approved | None posted |
| Jun 5, 1990 | Supplement 39Labeling | Approved | None posted |
| Sep 15, 1989 | Supplement 37Labeling | Approved | None posted |
| May 31, 1989 | Supplement 38Manufacturing | Approved | None posted |
| Jun 27, 1988 | Supplement 35Manufacturing | Approved | None posted |
| Feb 11, 1983 | Supplement 29Manufacturing | Approved | None posted |
| Feb 11, 1983 | Supplement 30Manufacturing | Approved | None posted |
| Dec 1, 1982 | Supplement 28Manufacturing | Approved | None posted |
| Jul 1, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters